News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
748,625 Results
Type
Article (72331)
Company Profile (414)
Press Release (675880)
Multimedia
Podcasts (106)
Webinars (13)
Section
Business (199739)
Career Advice (3532)
Deals (36484)
Drug Delivery (121)
Drug Development (86194)
Employer Resources (182)
FDA (16859)
Job Trends (15642)
News (349114)
Policy (34382)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (9)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (14)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (7)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (10)
2024 Pharm Country Digital (9)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2988)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (90)
Alliances (50461)
ALS (96)
Alzheimer's disease (1480)
Antibody-drug conjugate (ADC) (138)
Approvals (16826)
Artificial intelligence (281)
Autoimmune disease (27)
Automation (15)
Bankruptcy (350)
Best Places to Work (12186)
BIOSECURE Act (19)
Biosimilars (115)
Biotechnology (315)
Bladder cancer (67)
Brain cancer (31)
Breast cancer (283)
Cancer (2231)
Cardiovascular disease (191)
Career advice (2995)
Career pathing (33)
CAR-T (164)
Cell therapy (459)
Cervical cancer (21)
Clinical research (69477)
Collaboration (862)
Compensation (515)
Complete response letters (29)
COVID-19 (2802)
CRISPR (45)
C-suite (245)
Cystic fibrosis (107)
Data (2104)
Decentralized trials (2)
Denatured (38)
Depression (51)
Diabetes (277)
Diagnostics (6678)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (130)
Drug pricing (122)
Drug shortages (33)
Duchenne muscular dystrophy (99)
Earnings (74632)
Editorial (43)
Employer branding (22)
Employer resources (158)
Events (119142)
Executive appointments (735)
FDA (18099)
Featured Employer (56)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (774)
Gene editing (115)
Generative AI (27)
Gene therapy (336)
GLP-1 (810)
Government (4983)
Grass and pollen (5)
Guidances (50)
Healthcare (20356)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (136)
Indications (27)
Infectious disease (2952)
Inflammatory bowel disease (149)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (94)
Interviews (681)
IPO (17046)
IRA (50)
Job creations (3914)
Job search strategy (2462)
Kidney cancer (10)
Labor market (35)
Layoffs (535)
Leadership (21)
Legal (8000)
Liver cancer (76)
Lung cancer (325)
Lymphoma (143)
Machine learning (5)
Management (63)
Manufacturing (306)
MASH (68)
Medical device (14008)
Medtech (14013)
Mergers & acquisitions (19992)
Metabolic disorders (737)
Multiple sclerosis (79)
NASH (23)
Neurodegenerative disease (107)
Neuropsychiatric disorders (31)
Neuroscience (2043)
NextGen: Class of 2025 (7298)
Non-profit (4913)
Northern California (2562)
Now hiring (32)
Obesity (399)
Opinion (271)
Ovarian cancer (76)
Pain (92)
Pancreatic cancer (82)
Parkinson's disease (155)
Partnered (21)
Patents (235)
Patient recruitment (103)
Peanut (51)
People (61988)
Pharmaceutical (81)
Pharmacy benefit managers (21)
Phase I (21668)
Phase II (30402)
Phase III (22734)
Pipeline (1159)
Policy (157)
Postmarket research (2951)
Preclinical (9517)
Press Release (71)
Prostate cancer (103)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (420)
Real estate (6449)
Recruiting (72)
Regulatory (23600)
Reports (42)
Research institute (2601)
Resumes & cover letters (552)
Rett syndrome (4)
RNA editing (4)
RSV (47)
Schizophrenia (75)
Series A (137)
Series B (87)
Service/supplier (12)
Sickle cell disease (58)
Southern California (2227)
Special edition (18)
Spinal muscular atrophy (163)
Sponsored (33)
Startups (3773)
State (2)
Stomach cancer (16)
Supply chain (67)
Tariffs (27)
The Weekly (66)
United States (22931)
Vaccines (750)
Venture capitalists (41)
Weight loss (284)
Women's health (38)
Worklife (19)
Date
Last 7 days (495)
Last 30 days (2320)
Last 365 days (34560)
2025 (9796)
2024 (36940)
2023 (41571)
2022 (52777)
2021 (57709)
2020 (56449)
2019 (50057)
2018 (37979)
2017 (35072)
2016 (35102)
2015 (40741)
2014 (34020)
2013 (30021)
2012 (31565)
2011 (31786)
2010 (30427)
Location
Africa (1050)
Alabama (58)
Alaska (7)
Arizona (212)
Arkansas (14)
Asia (43932)
Australia (7837)
California (5921)
Canada (1954)
China (515)
Colorado (263)
Connecticut (282)
Delaware (136)
Europe (101946)
Florida (878)
Georgia (207)
Idaho (62)
Illinois (586)
India (27)
Indiana (308)
Iowa (10)
Japan (154)
Kansas (105)
Kentucky (25)
Louisiana (11)
Maine (70)
Maryland (897)
Massachusetts (4582)
Michigan (229)
Minnesota (389)
Mississippi (2)
Missouri (85)
Montana (30)
Nebraska (24)
Nevada (58)
New Hampshire (69)
New Jersey (1718)
New Mexico (31)
New York (1702)
North Carolina (1041)
North Dakota (8)
Northern California (2562)
Ohio (205)
Oklahoma (15)
Oregon (38)
Pennsylvania (1321)
Puerto Rico (12)
Rhode Island (30)
South America (1405)
South Carolina (20)
South Dakota (1)
Southern California (2227)
Tennessee (97)
Texas (880)
Utah (181)
Virginia (143)
Washington D.C. (62)
Washington State (561)
West Virginia (3)
Wisconsin (60)
748,625 Results for "ben gurion university of the negev".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Ben-Gurion University and Soroka Medical Center Announce Strategic Collaboration for Novel Technologies in the Field of Bio-Convergence
Ben-Gurion University of the Negev (BGU) and Soroka Medical Center announced a strategic collaboration for the development of novel technologies in the filed of Bio-Convergence (a field that combines biology with computational technologies and engineering).
May 4, 2022
·
7 min read
Drug Development
Ben-Gurion University Researchers to Develop Novel Biological Treatment for Inflammatory Bowel Diseases
Researchers at Ben-Gurion University of the Negev are developing a novel therapeutic strategy for treating Inflammatory Bowel Diseases by sequestering inflammation-inducing molecules secreted by gut bacteria.
August 11, 2021
·
4 min read
MASH
7 Late-Stage MASH Candidates That Could Reshape the Market
Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic dysfunction-associated steatohepatitis to a market that could reach $16 billion by 2033.
April 7, 2025
·
6 min read
·
Ben Hargreaves
Business
Actio Biosciences Appoints Ben Cravatt, Ph.D., to Board of Directors
Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, today announced that Ben Cravatt, Ph.D., has joined the company’s board of directors.
May 22, 2024
·
2 min read
Press Releases
Negev Labs Emerges from Stealth with Announcement of Alexander Shulgin Research Institute Licensing Agreement, Acquisition of Beckley Psytech Development Program and R&D Collaboration with Hadassah Brain Labs Center for Psychedelic Research
December 11, 2024
·
6 min read
Business
OncoHost Collaborates with BGN Technologies to Predict Cancer Patient Response to Anti-PD-1 Treatment with IcAR Biosensing Tech
OncoHost today announced that it has signed an option agreement with BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev (BGU), to receive a license for a novel biosensing technology called IcAR (Immuno-checkpoint Artificial Reporter). IcAR was developed by a team of researchers from BGU.
May 4, 2023
·
4 min read
Ben-Gurion University Researchers Develop Machine Learning Platform to Streamline Clinical Trials
Researchers at Ben-Gurion University of the Negev (BGU) have developed a novel platform to streamline clinical trials, lower costs, and increase the efficiency and success rate of the drug or medical device development process.
October 21, 2020
·
3 min read
Press Releases
Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors
October 23, 2024
·
4 min read
Researchers at Ben-Gurion University Introduce Platform for the Design of New Antibiotics
BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev, introduces a novel method developed by researchers at Ben-Gurion University for screening and detecting new antibiotics.
February 10, 2020
·
3 min read
Drug Delivery
Explainer: The Thriving Shadow Market of GLP-1s for Weight Loss
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The situation is causing the FDA regulatory headaches and, more seriously, posing potential risks to the public.
February 11, 2025
·
5 min read
·
Ben Hargreaves
1 of 74,863
Next
